Drug Database
HY

hyaluronic acid (BioHy / Euflexxa / BioLon)

✓ Approved

Johnson & Johnson Services, Inc. · 治疗药物

什么是 hyaluronic acid?

hyaluronic acid 是一种治疗药物,由Johnson & Johnson Services, Inc.研发。该药已获批,用于治疗相关适应症,给药途径:Injectable (Others)、Intraarticular Injection。

药物档案

商品名BioHy, Euflexxa, BioLon
公司Johnson & Johnson Services, Inc.
给药途径Injectable (Others), Intraarticular Injection
状态Approved

治疗适应症

hyaluronic acid 针对 4 个适应症,涉及 3 个治疗领域。

治疗领域疾病/病症分期
Eye disordersGlaucoma✓ Approved
Musculoskeletal and connective tissue disordersOsteoarthritis✓ Approved
Surgical and medical proceduresAdjuvant therapy✓ Approved
Eye disordersDry eyePhase II

相关研究文献

PubMedACS biomaterials science & engineering2026-11-19

Three-Dimensional Printable Human Platelet Lysate Methacrylate/Hyaluronic Acid Methacrylate/Nanohydroxyapatite Nanocomposite Hydrogels with Enhanced Mechanical and Rheological Properties for Tissue Engineering.

Şeker Şükran Ş, Ladeira Bruno M BM, Cleymand Franck F, Correia Tiago R TR et al.

Human platelet lysate-based hydrogels have gained increasing attention as a xeno-free platform for tissue engineering due to their potential to support cell viability and biological activity. Human-derived platelet lysate methacrylate (hPLMA) is a recently developed photocrosslinkable material that enables the formation of three-dimensional (3D) hydrogels through light-induced crosslinking of blood-derived proteins. However, evaluating hPLMA in different hydrogel formulations may provide further insight into its potential for advanced applications. In this study, hyaluronic acid methacrylate (HAMA, 1% w/v) and nanohydroxyapatite (nHAp, 5% w/v) were incorporated into hPLMA to develop a photocrosslinkable nanocomposite hydrogel (hPLMA/HAMA/nHAp). The incorporation of HAMA increased the compressive strength from 2.1 ± 0.9 kPa to 4.5 ± 1.5 kPa, resulting in an approximately 40-fold increase in the storage modulus while preserving shear-thinning behavior. The composite hydrogels exhibited sustained release of platelet-derived growth factor-AB (PDGF-AB) and vascular endothelial growth factor (VEGF) over 9 days and supported human adipose stem cell (hASC) viability (>93% for all formulations). Furthermore, extrusion-based 3D printing enabled the fabrication of grid-shaped constructs with maintained porosity, demonstrating moderate printability and shape fidelity of the constructs. While the independent contribution of nHAp remains to be investigated in future studies, the results demonstrate that the incorporation of HAMA improves the mechanical and rheological properties of the hPLMA/nHAp hydrogel, highlighting its potential for future tissue engineering applications.

PMID 43052217
阅读全文 →
PubMedJournal of the American Chemical Society2026-11-19

Facile Maleimide-Hydrazine Reaction to Form Stable Bonds in Dynamic Hydrazone-Cross-Linked Hydrogels.

Jaeschke Matthew W MW, Worthington Kendra K, Nelson Benjamin R BR, Kirkpatrick Bruce E BE et al.

The hydrazone bond has been extensively used in dynamic hydrogels but is limited in applications where stability is also required. Here, we demonstrate hydrazine cross-linking with both aldehydes and maleimides under physiological conditions (pH = 7.4 and 37 °C), enabling a one-pot reaction to form dynamic hydrazone and stable hydrazinosuccinimide bonds. Using poly(ethylene glycol) (PEG) and hyaluronic acid (HA) functionalized macromers, hydrogel-forming reactions between maleimide and amine-containing functional groups occurred most rapidly with alkyl-hydrazine through an aza-Michael addition mechanism. Hydrazinosuccinimide cross-links also exhibited enhanced stability compared to alkyl-hydrazone and benzyl-hydrazone cross-links. Lastly, hydrazinosuccinimide cross-linked PEG-HA hydrogels were functionalized with a cell-adhesive peptide via hydrazinosuccinimide, thiosuccinimide, or benzyl-hydrazone bonds, and human mesenchymal stem cell migration depended on the cross-linker structure and dynamicity. This reaction between maleimide and alkyl-hydrazine not only expands the range of accessible properties in dynamic hydrazone-cross-linked hydrogels but also broadens the available reactions maleimide can undergo for numerous biomaterial applications.

PMID 43053373
阅读全文 →
PubMedAnimal microbiome2026-11-19

Dose-dependent microbiome, metabolome and lipidome shifts in a mouse model of colitis-associated colorectal cancer using azoxymethane and dextran sodium sulphate.

Van Dingenen Lena L, Segers Charlotte C, Mysara Mohamed M, Osang'ir Bernard Isekah BI et al.

Colorectal cancer (CRC) remains a major health burden, underscoring the need for continued research to improve screening methods and treatment outcomes. The colitis-associated azoxymethane (AOM) and dextran sodium sulphate (DSS) mouse model has proven valuable for CRC research, as it closely mimics human CRC development and captures the complex interactions between the gut microbiome and immune system. However, variations in AOM/DSS dosing reported in literature can influence baseline conditions, thereby affecting the outcome and interpretation of experimental and therapeutic interventions. This study evaluated the impact of varying AOM and DSS doses on CRC development and the gut microbiome, metabolome and lipidome in mouse faeces (n = 29). Inflammation-driven CRC progression was more pronounced in mice treated with high-dose AOM (12.5 mg/kg) combined with high-dose DSS (2%) than in those receiving lower doses. Faecal 16S rRNA-based microbiome analysis revealed significant shifts in the high-dose AOM groups, which coincided with the highest tumour burden. Operational taxonomic units (OTUs) belonging to Prevotella, Turicibacter, Intestinimonas and Akkermansia muciniphila displayed patterns linked to inflammation and tumour progression, with distinct temporal abundance increases across AOM/DSS dosing groups. State-of-the-art, validated UHPLC-HRMS methodologies for faecal metabolomics and lipidomics fingerprinting (7951 features) and profiling (202 targets) identified imidazolepropionic acid, a microbe-derived metabolite, as a candidate biomarker associated with inflammation-driven CRC. In addition, mice with a high tumour burden presented elevated levels of lactic acid and γ-glutamylphenylalanine as well as decreased levels of fumaric acid, 6-deoxygalactose, glucosamine/mannosamine and L-threonine, all of which are associated with gut barrier dysfunction and inflammation. Furthermore, there was a decreased abundance of a short-chain acylcarnitine and both odd-chain and even-chain fatty acids, suggesting that altered energy metabolism may be associated with CRC progression. Multi-omics integration revealed a factor shaped by differential contributions from metabolites and lipids linked to Lachnospiraceae spp., with compounds like lactic acid, methylmalonic acid, linoleic acid and palmitoleic acid positively associated with inflammation and CRC, while hypoxanthine, nicotinic acid/2-picolinic acid, L-carnitine and deoxycarnitine, showed potential protective associations. These findings highlight the complex interplay between gut inflammation, microbiome dynamics and metabolic reprogramming in CRC and suggest that AOM/DSS dosing substantially influences these interactions.

PMID 43053245
阅读全文 →
PubMedJournal of translational medicine2026-11-19

Metabolic remodeling in early- and late-onset colorectal cancer supports an age-informed detection model.

Wang Ruowei R, Wang Weifeng W, Liao Leen L, Zheng Muxu M et al.

The incidence of early-onset colorectal cancer (EOCRC) has increased in recent decades; however, most metabolomic studies have focused on all age groups. Consequently, it remains uncertain how metabolic alterations drive EOCRC progression and whether biomarker signatures identified in older patients are valid in younger populations. We performed untargeted plasma metabolomic profiling of 791 participants, including those with colorectal cancer (CRC), colorectal adenoma (CRA), and healthy controls. Individuals were stratified by age (<50 and ≥50 years) to explore metabolic remodeling during EOCRC and late-onset CRC (LOCRC) development. A multistep feature selection process and 12 machine learning algorithms were used to establish an age-informed CRC detection model. CRC progression was associated with the suppression of caffeine and histidine metabolism and the enhancement of amino acid metabolism, particularly branched-chain amino acid, glycine-serine, and arginine-proline pathways. EOCRC showed increased phenylalanine, butanoate, and lipoic acid metabolism, whereas LOCRC was enriched in purine and fatty acid biosynthesis. A 7-metabolite panel (caffeine, ergothioneine, hypoxanthine 1, L-valyl-L-alanine, L-seryl-L-aspartic acid, cholic acid, and cycloleucine) was trained and achieved excellent detection values in all age groups (AUC > 0.95). SHapley Additive exPlanations (SHAP) analysis highlighted metabolite-specific contributions, supporting biological interpretability. These findings delineate age-related metabolic remodeling in CRC and demonstrate that integrating plasma metabolomics with machine learning supports a robust and interpretable non-invasive detection approach. The proposed age-informed model may inform future age-tailored CRC detection strategies amid the increasing burden of early-onset cancers.

PMID 43053157
阅读全文 →
PubMedNature communications2026-11-19

Metabolic engineering and deep learning-driven protein engineering for N-Acetylneuraminic acid biosynthesis in Escherichia coli.

Wang Nan-Kai NK, Yue Song S, Chen Jin-Ping JP, Su Chang C et al.

N-Acetylneuraminic acid (NeuAc) is a sialic acid valued in pharmaceuticals and infant nutrition, and microbial synthesis offers a scalable route once the pathway's catalytic bottlenecks are relieved. We combine deep learning with metabolic engineering to build a high-titer NeuAc-producing E.coli strain. Modular pathway engineering reaches 1.25 g L-1 and pinpoints N-acetylglucosamine 2-epimerase (AGE) as the rate-limiting step. We develop DLCatalysis, a deep learning framework that predicts kcat Km-1 directly from protein sequence and substrate, and use it to mine AGEBf that lifts the titer to 6.84 g L-1. DLCatalysis-guided redesign of AGEBf and NeuBNm raises NeuAc to 9.27 g L⁻¹, and identifying and deleting exuT, a previously unannotated NeuAc transporter, blocks product reuptake. In 5-L fed-batch fermentation the optimized strain produces 85.5 g L-1, showing that AI-guided enzyme discovery can resolve the bottlenecks that have limited microbial NeuAc production.

PMID 43052267
阅读全文 →
PubMedWorld journal of gastrointestinal oncology2026-11-19

Correction to "Impact of Alcian blue and periodic acid Schiff expression on the prognosis of gastric signet ring cell carcinoma".

Lin Juan J, Chen Zhu-Feng ZF, Guo Guo-Dong GD, Chen Xin X

[This corrects the article DOI: 10.4251/wjgo.v16.i3.687.].

PMID 43053751
阅读全文 →

注册免费账户还可查看另外 9996 篇文献

免费注册查看全部文献 →

了解更多hyaluronic acid